MDPI and ACS Style
Alhalmi, A.; Amin, S.; Khan, Z.; Beg, S.; Al kamaly, O.; Saleh, A.; Kohli, K.
Nanostructured Lipid Carrier-Based Codelivery of Raloxifene and Naringin: Formulation, Optimization, In Vitro, Ex Vivo, In Vivo Assessment, and Acute Toxicity Studies. Pharmaceutics 2022, 14, 1771.
https://doi.org/10.3390/pharmaceutics14091771
AMA Style
Alhalmi A, Amin S, Khan Z, Beg S, Al kamaly O, Saleh A, Kohli K.
Nanostructured Lipid Carrier-Based Codelivery of Raloxifene and Naringin: Formulation, Optimization, In Vitro, Ex Vivo, In Vivo Assessment, and Acute Toxicity Studies. Pharmaceutics. 2022; 14(9):1771.
https://doi.org/10.3390/pharmaceutics14091771
Chicago/Turabian Style
Alhalmi, Abdulsalam, Saima Amin, Zafar Khan, Sarwar Beg, Omkulthom Al kamaly, Asmaa Saleh, and Kanchan Kohli.
2022. "Nanostructured Lipid Carrier-Based Codelivery of Raloxifene and Naringin: Formulation, Optimization, In Vitro, Ex Vivo, In Vivo Assessment, and Acute Toxicity Studies" Pharmaceutics 14, no. 9: 1771.
https://doi.org/10.3390/pharmaceutics14091771